Dr Michelle Dickinson: nanotechnologist on the new eye drop treatment that promises to restore vision loss episode artwork

EPISODE · Sep 20, 2025 · 3 MIN

Dr Michelle Dickinson: nanotechnologist on the new eye drop treatment that promises to restore vision loss

from The Sunday Session with Francesca Rudkin · host Newstalk ZB

If you’ve found yourself holding a book at arm’s length or squinting at your phone in dim light, you’re not alone. Almost everyone develops presbyopia as they get older. It’s a natural part of aging where the eye’s lens loses flexibility, making it harder to focus on nearby objects.  Traditionally, the go-to solution has been reading glasses, or, for some, surgery. But now, a surprising contender is on the horizon: eye drops.  At the recent Congress of the European Society of Cataract and Refractive Surgeons, researchers presented results that could change how presbyopia is treated. In a study of 766 patients, eye drops combining pilocarpine and diclofenac helped people read extra lines on a near-vision chart, and the improvements lasted for up to two years.  The drops contain two active ingredients working in tandem:  Pilocarpine: an older drug that contracts the eye’s ciliary muscle and makes the pupil smaller. This helps sharpen focus for near objects. Diclofenac: a common anti-inflammatory drug that eases the discomfort pilocarpine can cause.  Together, they act like a workout and cushion for the eye: one trains the focusing muscles, the other keeps irritation at bay.  Patients in the study used the drops twice a day once in the morning and once later in the afternoon, with the option for a third dose if needed.  The findings were striking:  Within one hour of the first dose, patients could typically read three extra lines on the near-vision chart. 99% of those using the lowest concentration (1% pilocarpine) gained at least two lines of improvement. For many, the improvements lasted more than a year, with some maintaining better vision for nearly two years. Side effects were mild and included temporary dim vision (32%), irritation (3.7%), and headaches (3.8%). Importantly, no serious complications like retinal detachment were reported.  Imagine a future where instead of fumbling for your reading glasses at dinner, you simply use an eye drop in the morning and carry on with clear sight throughout the day.  LISTEN ABOVESee omnystudio.com/listener for privacy information.

Episode metadata supplied by the publisher feed · Published Sep 20, 2025

Embed this episode

NOW PLAYING

Dr Michelle Dickinson: nanotechnologist on the new eye drop treatment that promises to restore vision loss

0:00 3:51

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Sunday Session with Francesca Rudkin?

This episode is 3 minutes long.

When was this The Sunday Session with Francesca Rudkin episode published?

This episode was published on September 20, 2025.

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this The Sunday Session with Francesca Rudkin episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!